Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
Moodys
Harvard Business School
Mallinckrodt

Last Updated: January 27, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Batefenterol


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Batefenterol?

Batefenterol is an investigational drug.

There have been 4 clinical trials for Batefenterol. The most recent clinical trial was a Phase 2 trial, which was initiated on December 1st 2015.

The most common disease conditions in clinical trials are Chronic Disease, Pulmonary Disease, Chronic Obstructive, and Lung Diseases. The leading clinical trial sponsors are GlaxoSmithKline, Hammersmith Medicines Research, and Theravance Biopharma.

There are seventeen US patents protecting this investigational drug and two hundred and forty international patents.

Recent Clinical Trials for Batefenterol
TitleSponsorPhase
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy SubjectsGlaxoSmithKlinePhase 1
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy SubjectsHammersmith Medicines ResearchPhase 1
A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy SubjectsTheravance BiopharmaPhase 1

See all Batefenterol clinical trials

Clinical Trial Summary for Batefenterol

Top disease conditions for Batefenterol
Top clinical trial sponsors for Batefenterol

See all Batefenterol clinical trials

US Patents for Batefenterol

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Batefenterol ⤷  Try it Free JAK inhibitors containing a 4-membered heterocyclic amide THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Try it Free
Batefenterol ⤷  Try it Free Fused imidazo-piperidine JAK inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Try it Free
Batefenterol ⤷  Try it Free JAK inhibitors containing a 4-membered heterocyclic amide THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Try it Free
Batefenterol ⤷  Try it Free Methods of treatment using a JAK inhibitor compound THERAVANCE BIOPHARMA R&D IP, LLC (South San Francisco, CA) ⤷  Try it Free
Batefenterol ⤷  Try it Free Fused imidazo-piperidine JAK inhibitors Theravance Biopharma R&D IP, LLC (South San Francisco, CA) ⤷  Try it Free
Batefenterol ⤷  Try it Free Methods of treatment using a JAK inhibitor compound Theravance Biopharma R&D IP, LLC (South San Francisco, CA) ⤷  Try it Free
Batefenterol ⤷  Try it Free JAK inhibitors containing a 4-membered heterocyclic amide Theravance Biopharma R&D IP, LLC (South San Francisco, CA) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Batefenterol

Drugname Country Document Number Estimated Expiration Related US Patent
Batefenterol Argentina AR111241 2037-03-09 ⤷  Try it Free
Batefenterol Argentina AR111242 2037-03-09 ⤷  Try it Free
Batefenterol Australia AU2018231032 2037-03-09 ⤷  Try it Free
Batefenterol Australia AU2018231035 2037-03-09 ⤷  Try it Free
Batefenterol Brazil BR112019018648 2037-03-09 ⤷  Try it Free
Batefenterol Brazil BR112019018649 2037-03-09 ⤷  Try it Free
Batefenterol Canada CA2997772 2037-03-09 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
AstraZeneca
Moodys
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.